Maternal pertussis vaccination has been introduced in several countries to protect infants
from birth until routine infant vaccination takes place. This review assesses existing …

The effectiveness of maternal immunization in preventing infant pertussis was first
demonstrated in England, 1 year after the program using diphtheria–tetanus–5-component …

Antecedentes En los procedimientos de vacunación se pueden utilizar agujas hipodérmicas
de diferentes tamaños (calibres y longitudes). El calibre (G, del inglés" gauge") se refiere al …

Background Maternal vaccination with an acellular pertussis (aP)–containing vaccine is a
recommended strategy in a growing number of industrialized countries, to protect young …

Background The variability of terms and definitions of Adverse Events Following
Immunization (AEFI) represents a missed opportunity for optimal monitoring of safety of …

Abstract Background In October 2012, a maternal pertussis vaccination program was
introduced in England for women between 28 and 32 weeks of pregnancy. In April 2016, the …

Background: To assess the immunogenicity and safety of a fully liquid, ready-to-use
hexavalent DTaP-IPV-HB-PRP-T vaccine when administered in a 2+ 1 schedule at 3, 5 and …

Background Protection induced by acellular pertussis (aP) vaccines is partial and short-
lived, especially in teenagers, calling for novel immunization strategies. Methods We …

Background Developing countries still struggle with late detection and mortality from
pertussis. A review of clinical case definitions is necessary for early disease detection. This …

Introduction An unexpected resurgence of pertussis cases and infant deaths was observed
in some countries that had switched to acellular pertussis vaccines in the primary …